Stage IV Gastric Cancer AJCC v7
6 clinical trials · Condition
◉ Watch Stage IV Gastric Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors (NCT02757391) | M.D. Anderson Cancer Center | 2019-08-09 |
| Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer (NCT03161522) | M.D. Anderson Cancer Center | 2018-02-19 |
| Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278) | National Cancer Institute (NCI) | 2018-02-06 |
| Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer (NCT03196232) | George Albert Fisher | 2017-09-13 |
| Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561) | National Cancer Institute (NCI) | 2016-02-01 |
Track Stage IV Gastric Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.